Tissium News and Activities

Acquisition, funding and merger involving Tissium.

• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).
• Tissium has just announced a $68 Million fundraising (posted on June 29 2026).
• Tissium has just announced a $60 Million fundraising (posted on June 25 2026).

View the org chart displaying its 26 main executives

Most searched biographies at Tissium

• Christophe Bancel, Chief Executive Officer and Director
• Michel Thérin, Director
• Mingpo Cai, Director

Popular executive movements at Tissium

• Marc Quartulli has joined the company as Vice President of Clinical Affairs  (posted on May 6 2026).
• Marie-Elena Brett who was Associate Director, Clinical Science, becomes Director of Clinical Science  (posted on May 6 2026).

Create your alert
to follow the executive moves at Tissium.

Tissium has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 9 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Tissium

• TISSIUM secures €60 million to support commercial and clinical activities and platform expansion - TISSIUM
• TISSIUM Selected to the French Tech Next40 Program - TISSIUM
• TISSIUM APPOINTS MARC QUARTULLI AS VICE PRESIDENT OF CLINICAL AFFAIRS - TISSIUM
• TISSIUM® ANNOUNCES PUBLICATION OF FIRST-IN-HUMAN CLINICAL RESULTS OF THE COAPTIUM® CONNECT SYSTEM FOR ATRAUMATIC SUTURELESS NERVE REPAIR IN JHSGO - TISSIUM
• Press Release Archives - Page 5 of 5 - TISSIUM
• TISSIUM Announces First Commercial Use of COAPTIUM® CONNECT for Peripheral Nerve Repair in the United States - TISSIUM
• TISSIUM Advances Clinical Pipeline in Hernia Repair Following First FDA Authorization - TISSIUM
• TISSIUM Announces U.S. Commercial Launch of COAPTIUM® Connect and Strategic Governance Evolution - TISSIUM
• TISSIUM Receives FDA De Novo Authorization for COAPTIUM® CONNECT in Atraumatic Sutureless Peripheral Nerve Repair - TISSIUM
• TISSIUM selected for the French Tech 120 Program - TISSIUM
• View more press releases Close

Social media about Tissium

• Tissium on Wikipedia, Google News & Yahoo Finance
• Tissium on LinkedIn, X (Twitter) & YouTube